Cargando…

Prophylactic Activated Recombinant Factor VII in Liver Resection and Liver Transplantation: Systematic Review and Meta-Analysis

BACKGROUND AND AIM: Intraoperative blood loss is a frequent complication of hepatic resection and orthotopic liver transplantation. Recombinant activated coagulation factor VII (rFVIIa) is a coagulation protein that induces hemostasis by directly activating factor X. There is no clear information ab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chavez-Tapia, Norberto C., Alfaro-Lara, Roberto, Tellez-Avila, Felix, Barrientos-Gutiérrez, Tonatiuh, González-Chon, Octavio, Mendez-Sanchez, Nahum, Uribe, Misael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3144913/ https://www.ncbi.nlm.nih.gov/pubmed/21818342 http://dx.doi.org/10.1371/journal.pone.0022581

Ejemplares similares

Nuclear Receptors in Nonalcoholic Fatty Liver Disease
por: López-Velázquez, Jorge A., et al.
Publicado: (2012)

A systematic review and meta-analysis of the use of oral zinc in the treatment of hepatic encephalopathy
por: Chavez-Tapia, Norberto C, et al.
Publicado: (2013)

Incremental levels of diagnostic information incentivize health-seeking in non-alcoholic fatty liver: a randomized clinical trial
por: Chavez-Tapia, Norberto C., et al.
Publicado: (2022)

Role of bioactive fatty acids in nonalcoholic fatty liver disease
por: Juárez-Hernández, Eva, et al.
Publicado: (2016)

Understanding the Relationship between Nonalcoholic Fatty Liver Disease and Thyroid Disease
por: Vidal-Cevallos, Paulina, et al.
Publicado: (2023)

Mitochondrial Molecular Pathophysiology of Nonalcoholic Fatty Liver Disease: A Proteomics Approach
por: Nuño-Lámbarri, Natalia, et al.
Publicado: (2016)

The diagnostic and initial approach of the patient with non-alcoholic fatty liver disease: role of the primary care provider
por: Salva-Pastor, Nicolás, et al.
Publicado: (2019)

Prebiotics and Probiotics: Therapeutic Tools for Nonalcoholic Fatty Liver Disease
por: Mijangos-Trejo, Alejandra, et al.
Publicado: (2023)

Prophylactic administration of recombinant activated factor VII in coronary revascularization surgery
por: Abdel-Meguid, Mohamed Essam
Publicado: (2013)

The Role of Dendritic Cells in Fibrosis Progression in Nonalcoholic Fatty Liver Disease
por: Almeda-Valdes, Paloma, et al.
Publicado: (2015)

COVID-19: Current Status in Gastrointestinal, Hepatic, and Pancreatic Diseases—A Concise Review
por: Aquino-Matus, Jorge, et al.
Publicado: (2022)

Hypoxic hepatitis in cardiac intensive care unit: a study of cardiovascular risk factors, clinical course, and outcomes
por: Chávez-Tapia, Norberto C, et al.
Publicado: (2014)

Cross-sectional pilot study to assess primary healthcare workers’ knowledge of nonalcoholic fatty liver disease in a marginalized community in Mexico
por: Vidal-Cevallos, Paulina, et al.
Publicado: (2021)

The fibrogenic process and the unleashing of acute-on-chronic liver failure
por: López-Sánchez, Guillermo Nahúm, et al.
Publicado: (2020)

Enlargements of the Liver.—VII
Publicado: (1910)

Use of recombinant activated factor VII for bleeding following resection of mediastinal angiosarcoma
por: Arora, D, et al.
Publicado: (2011)

Diagnostic accuracy of nodular gastritis for H. pylori infection
por: Romero-Flores, Juan L, et al.
Publicado: (2016)

Herbal Medicine in Mexico: A Cause of Hepatotoxicity. A Critical Review
por: Valdivia-Correa, Bárbara, et al.
Publicado: (2016)

Systematic review and meta-analysis of the efficacy of prophylactic abdominal drainage in major liver resections
por: Dezfouli, Sepehr Abbasi, et al.
Publicado: (2021)

Acute-on-chronic liver failure: a review
por: Zamora Nava, Luis Eduardo, et al.
Publicado: (2014)

Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease
por: Chavez-Tapia, Norberto C, et al.
Publicado: (2012)

Safely Modified Laparoscopic Liver Resection for Segment VI and/or VII Hepatic Lesions Using the Left Lateral Decubitus Position
por: Xiao, Min, et al.
Publicado: (2022)

Understanding the Role of Metabolic Syndrome as a Risk Factor for Hepatocellular Carcinoma
por: Chavez-Tapia, Norberto C, et al.
Publicado: (2022)

Low–Normal Thyroid Function Is Not Associated with Either Non-Alcoholic Fatty Liver Disease or with Metabolic Dysfunction-Associated Fatty Liver Disease
por: Zuarth-Vázquez, Julia, et al.
Publicado: (2023)

Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven(®))
por: Bartosh, Nicole S, et al.
Publicado: (2013)

Overview of the human pharmacokinetics of recombinant activated factor VII
por: Klitgaard, Thomas, et al.
Publicado: (2008)

Treatment of obstetric hemorrhage with recombinant activated factor VII
por: Czuprynski, P, et al.
Publicado: (2009)

Recombinant activated factor VII in post partum haemorrhage
por: Magon, Navneet, et al.
Publicado: (2013)

The role of recombinant activated factor VII in cardiac surgery
por: Richardson, A, et al.
Publicado: (2009)

Editorial: International Consensus Recommendations to Replace the Terminology of Non-Alcoholic Fatty Liver Disease (NAFLD) with Metabolic-Associated Fatty Liver Disease (MAFLD)
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2021)

The safety of omitting prophylactic abdominal drainage after laparoscopic liver resection: Retrospective analysis of 100 consecutive cases
por: Wakasugi, Masaki, et al.
Publicado: (2020)

Timing for removing prophylactic drains after liver resection: an evaluation of drain removal on the third and first postoperative days
por: Ichida, Akihiko, et al.
Publicado: (2020)

Resection of the Liver
Publicado: (1890)

A novel method of ultrasound-guided positive staining using indocyanine green fluorescence in laparoscopic anatomical liver resection of segments VII and VIII
por: Jiang, Zedong, et al.
Publicado: (2023)

Activated recombinant factor VII in management of bleeding in patients with thrombocytopenia
por: Shulutko, E, et al.
Publicado: (2006)

Recombinant activated factor VII: does it really save lives?
por: Edke, U
Publicado: (2009)

Recombinant activated factor VII for uncontrolled bleeding postcardiac surgery
por: Habib, Aly Makram, et al.
Publicado: (2016)

The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia
por: Poon, Man-Chiu
Publicado: (2021)

Systematic review and meta-analysis on the adverse events of rimonabant treatment: Considerations for its potential use in hepatology
por: Chavez-Tapia, Norberto C, et al.
Publicado: (2009)

The mechanism of dysbiosis in alcoholic liver disease leading to liver cancer
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q04qdb4n57is58fjb260qkrfhm